Insider · CIK 0001500210
Bailey Jeffrey Allen
Reports to the SEC for 10 companies · EDMONTON
Transactions
50
Companies
10
Filings
9
CIK
0001500210
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-04 | AUPHAurinia Pharmaceuticals Inc. · Director Stock Option (right to buy)A Award | — |
| 2025-11-21 | AUPHAurinia Pharmaceuticals Inc.F Tax Payment | −$42.6K |
| 2025-05-16 | AUPHAurinia Pharmaceuticals Inc. · Director Stock Option (right to buy)A Award | — |
| 2024-11-21 | AUPHAurinia Pharmaceuticals Inc.A Award | — |
| 2024-11-21 | AUPHAurinia Pharmaceuticals Inc. · Director Stock Option (right to buy)A Award | — |
| 2024-11-11 | AUPHAurinia Pharmaceuticals Inc.S Sale | −$38.4K |
| 2024-11-08 | AUPHAurinia Pharmaceuticals Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-11-08 | AUPHAurinia Pharmaceuticals Inc.M Exercise/Conversion | — |
| 2023-08-18 | AUPHAurinia Pharmaceuticals Inc. · Stock Option (right to buy)A Award | — |
| 2023-08-18 | AUPHAurinia Pharmaceuticals Inc. · Restricted Stock UnitsA Award | — |
| 2022-06-15 | RNTXRein Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-03-22 | BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsD Disposition to Issuer | — |
| 2022-03-22 | BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)D Disposition to Issuer | — |
| 2022-03-22 | BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)D Disposition to Issuer | — |
| 2022-03-22 | BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)D Disposition to Issuer | — |
| 2022-03-22 | BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)D Disposition to Issuer | — |
| 2022-03-22 | BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)D Disposition to Issuer | — |
| 2022-03-22 | BIODELIVERY SCIENCES INTERNATIONAL INCJ Other | — |
| 2022-03-09 | BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion | — |
| 2022-03-09 | BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsM Exercise/Conversion | — |
| 2022-01-27 | BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)A Award | +$4.19M |
| 2022-01-27 | BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsA Award | — |
| 2021-11-04 | BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion | — |
| 2021-11-04 | BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsM Exercise/Conversion | — |
| 2021-08-06 | BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion | — |
| 2021-08-06 | BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsM Exercise/Conversion | — |
| 2021-06-15 | RNTXRein Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2021-04-06 | THWabrdn World Healthcare Fund · Subscription RightsX Exercise of In-Money | — |
| 2021-04-06 | THWabrdn World Healthcare FundX Exercise of In-Money | +$3,494.19 |
| 2021-03-09 | BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsM Exercise/Conversion | — |
| 2021-03-09 | BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion | — |
| 2020-12-15 | BIODELIVERY SCIENCES INTERNATIONAL INCS Sale | −$43.5K |
| 2020-11-04 | BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion | — |
| 2020-11-04 | BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsA Award | — |
| 2020-11-04 | BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsM Exercise/Conversion | — |
| 2020-11-04 | BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)A Award | — |
| 2020-09-23 | HQHabrdn Healthcare InvestorsP Purchase | +$9,991.1 |
| 2020-09-23 | THWabrdn World Healthcare FundP Purchase | +$10.1K |
| 2020-09-23 | THQabrdn Healthcare Opportunities FundP Purchase | +$10.1K |
| 2020-09-22 | HQLabrdn Life Sciences InvestorsP Purchase | +$10K |
| 2020-08-07 | BIODELIVERY SCIENCES INTERNATIONAL INCM Exercise/Conversion | — |
| 2020-08-07 | BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsM Exercise/Conversion | — |
| 2020-07-30 | BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)A Award | — |
| 2020-07-30 | BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsA Award | — |
| 2020-06-17 | RNTXRein Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2020-05-10 | BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)A Award | — |
| 2020-05-10 | BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsA Award | — |
| 2020-03-09 | BIODELIVERY SCIENCES INTERNATIONAL INCRestricted Stock UnitsA Award | — |
| 2020-03-09 | BIODELIVERY SCIENCES INTERNATIONAL INCStock Options (right to buy)A Award | — |
| 2019-11-15 | RNTXRein Therapeutics, Inc.P Purchase | +$20K |
Recent filings
- 4Bailey Jeffrey Allen0001500210-26-000002SEC(opens sec.gov)
- 4Bailey Jeffrey Allen0001600620-25-000110SEC(opens sec.gov)
- 4Bailey Jeffrey Allen0001600620-25-000075SEC(opens sec.gov)
- 4Bailey Jeffrey Allen0001600620-24-000120SEC(opens sec.gov)
- 4Bailey Jeffrey Allen0001600620-24-000116SEC(opens sec.gov)
- 4Bailey Jeffrey Allen0001600620-23-000038SEC(opens sec.gov)
- 4Bailey Jeffrey Allen0000899243-22-023133SEC(opens sec.gov)
- 4Bailey Jeffrey Allen0001103021-22-000065SEC(opens sec.gov)
- 4Bailey Jeffrey Allen0001103021-22-000053SEC(opens sec.gov)
Companies
- abrdn Healthcare InvestorsDirectorHQH
- abrdn Healthcare Opportunities FundDirectorTHQ
- abrdn Life Sciences InvestorsDirectorHQL
- abrdn World Healthcare FundDirectorTHW
- Aurinia Pharmaceuticals Inc.DirectorAUPH
- BIODELIVERY SCIENCES INTERNATIONAL INCDirector, Chief Executive Officer
- KING PHARMACEUTICALS INCChief Commercial Officer
- LANDAUER INCDirector
- Lantheus Holdings, Inc.Director, CEO and PresidentLNTH
- Rein Therapeutics, Inc.DirectorRNTX
Address
#140, 14315-118 AVENUE
EDMONTON, T5L 4S6